Josh Berlin

Last Call: Advanced Rate Discount. 26th #BioEquityEurope. Register or apply to present by April 2 to lock in the price. No biotech event has a higher concentration of investors. Visit our website to see the full list of faculty (including ones below). conferences.biocentury.com/bioequity-euro…

In 2 weeks @BioCentury is in Seoul for our 5th East-West Summit → Networking, partnering, debate → Biotechs/VCs from Korea, China, Japan, Singapore & beyond → @McKinsey conf report → Overnight Daejeon tour: See Korea's innovation moment for yourself conferences.biocentury.com/east-west-summ…

@MattGardnerBio @BioCentury @CBRE Hah! The #WorldSockTour is something I can get behind! Great seeing you.

Hey @BioPharmaJosh just wanted to make sure you know the @BioCentury #WorldSockTour is under way with a visit to Dallas and @CBRE HQ today!

Hope to see you next week in Boston/Cambridge!

Don't be late to the Korea story. Join @BioCentury, BayHelix, Insights Partner @McKinsey and Regional Host Chair @bio_korea in Seoul, March 9-11, for our 5th East-West Biopharma Summit -- focused on Asia's emerging Arc of Innovation. ✅ Register: conferences.biocentury.com/east-west-summ…

Partnering is open for BioCentury's 12th China Healthcare Summit (Shanghai, Oct. 22-24). Please send a DM if you have questions. Hope to see you there! Check out the agenda: conferences.biocentury.com/china-healthca… #BioCenturyChinaSummit #biotech #pharma #dealmaking

Last call! Join @BioCentury Grand Rounds (Cambridge, UK, Sept. 17-19): Debate how to make early-stage R&D investible. ➣ Partnering is open ➣ Sold-out Presenting Company Track ➣ Sold-out Academic Poster Session ➣ Agenda: conferences.biocentury.com/grand-rounds-e… #BioCenturyGrandRounds

Biotech IPOs, FDA-Stealth & patent threat — on the latest #BioCenturyThisWeek podcast with @SteveUsdin1 @BioPharmaJosh @BioBonanos @Jeff_Cranmer buff.ly/O8Zk0aw

Advanced Rate Discount ends Aug. 15 for Grand Rounds-Europe (Cambridge, UK, Sept. 17-19). This BioCentury conference focused on key bottlenecks in translation and how to make early-stage R&D investible. Register: conferences.biocentury.com/grand-rounds-e… Hope to see you there!

Asia deals: Globalization is open for business. An analysis of 198 Asia deals in the last 2.5 years finds Western biotechs are engaging even more than pharmas. A breakdown of deal values, therapeutic areas, modalities and first-in-class potential. buff.ly/ecWluUy

A new way of thinking about academia-industry collaboration — a special #BioCenturyGrandRounds edition of the #BioCenturyThisWeek podcast featuring @FishburnSimone & @BioPharmaJosh, top BioCentury analysts and special guests buff.ly/VC9BUzN

Debate key bottlenecks in translation. Join us June 4-6 in Chicago (after #ASCO25) for 2nd BioCentury Grand Rounds R&D Conference. We will also host a European edition, Sept. 17-19, Cambridge, U.K. Hope to see you there! #BioCenturyGrandRounds conferences.biocentury.com/grand-rounds-us

Looking for investors? No #biotech event attracts more VCs than #BioEquityEurope. Join us May 12-14 in Bruges, Belgium, to celebrate the 25th edition of this destination event for CEOs and investors. BioEquityEurope.com

Early Bird for BioCentury's 4th East-West Biopharma Summit ends Dec. 31. Join us in Singapore, March 2025, for a #biotech CEO & Investor conference focused on the emerging Arc of Innovation across Asia. ✅Register: conferences.biocentury.com/east-west-summ… #BioCenturyEastWest

Are you attending London Life Sciences Week? If so, join @BioCentury and @BIA_UK Nov. 19 (5pm-9pm) for our 2nd CEO and Investor Dialogue and networking reception. Includes fireside chat w/ @EricTokat of Centerview. conferences.biocentury.com/jefferies-uk-2… Hope to see you there! #LLSW2024

It was great joining the BioCentury This Week podcast to talk shop with ⁦@jeff_cranmer⁩ about our 11th China Healthcare Summit + Cincinnati chili, Kentucky bourbon & Bengals/Ravens - How about that list? Give a listen on your morning run or walk! podcasts.apple.com/us/podcast/bio…

Beating the bear: 4Q24 Public Markets Preview on a new #BioCenturyThisWeek podcast. Plus: Introducing this year’s China Summit, and what’s eating @US_FDA’s advisory committees? with @StephenPHansen @BiopharmaJosh @SteveUsdin1 @Jeff_Cranmer buff.ly/4eP0XVy

Last Call for Advanced Rate Discount for 11th BioCentury-BayHelix China Healthcare Summit (Shanghai, Oct. 30-Nov. 1). Register by Sept. 30 to save: conferences.biocentury.com/china-healthca… Can't join in Shanghai? Register for a Digital Pass instead.

Incubated by Samsara, led by ex $GILD liver disease top cat Mani Subramanian, OrsoBio now has $164M+ after a series B co-led by Ascenta, Woodline. @BioCentury's @BioBonanos spoke w/ Mani last fall about modulating energy to address obesity, diabetes & more biocentury.com/article/650574

Eyes on the Target: In this year's Back to School essays, BioCentury asks whether the era of human first, causal biology and personalized medicine can reshape drug discovery to solve the weakest link in biotech -- translation to the clinic. buff.ly/3z4Xvae